Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- LifeCycle Pharma to Webcast Presentation at UBS Global Life Sciences Conference
- HORSHOLM, Denmark -- LifeCycle Pharma A/S (OMX:LCP), an emerging specialty pharmaceutical company focused on developing and commercializing differentiated versions of existing drugs in large therapeutic areas such as cardiovascular disease, organ transplantation and immunosuppression, including recently Food and Drug Administration approved LCP-FenoChol, a fenofibrate for the treatment of hyperlipidemia and...
- Research articles 2007-09-18
- ProEthic Pharmaceuticals Selects I-many ContractSphere® for Life Sciences; Leading Pharmaceutical Company to Leverage I-many ContractSphere® for Life Sciences as the Foundation to Automate and Streamline Medicaid Claims Processing
- EDISON, N.J. -- I-many, Inc. (NASDAQ:IMNY), a provider of advanced Enterprise Contract Management ECM solutions for managing corporate commitments, today announced that ProEthic Pharmaceuticals has chosen I-many Medicaid to automate the management and tasks involved in processing Medicaid claims. The solution will help ProEthic gain control over Medicaid processing costs,...
- Research articles 2005-06-28
- Axcan Pharma to Present at the UBS Global Life Sciences Conference.(Conference news)
- MONT-SAINT-HILAIRE, QUEBEC, Sep 19, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX:AXP)(NASDAQ:AXCA) today announced that on Wednesday, September 26, 2007, President and Chief Executive Officer, MONT-SAINT-HILAIRE, QUEBEC, Sep 19, 2007 CCNMatthews via COMTEX -- Axcan Pharma Inc. ("Axcan" or the...
- Research articles 2007-09-19
- Leading Pharmaceutical Company in China Selects CDC Software's Ross ERP; Life Science Expertise, Application Functionality, and Ability to Deliver Rapid ROI Drive Kunming Jida Pharmaceutical's Selection Process
- BEIJING, China & ATLANTA -- CDC Software, a subsidiary of CDC Corporation (NASDAQ: CHINA), today announced that Kunming Jida Pharmaceutical, the leading pharmaceutical company in China, has selected its Ross ERP application due to its focus on life sciences, deep application functionality, and proven ability to rapidly deliver a return...
- Research articles 2006-07-05
- European specialty players revamp and replace their strategy. (Focus 2003: Specialty Chemicals/ChemSpec Europe Preview).
- Threatened with commoditization, companies take drastic measures, not only cutting costs and divesting operations, but also seeking an entirely different, closer relationship with their customers. Under pressure from sluggish demand, difficult Threatened with commoditization, companies take drastic measures, ...
- Research articles 2003-04-28
- Merck Expands Contract Manufacture As Part of Major Reorganization Plan.(Brief Article)
- MERCK KGAA plans a major expansion in pharmaceutical and agrochemical contract manufacturing as part of a reorganization of its chemicals and laboratory products operations. The company is combining its specialty chemicals and laboratory prod MERCK KGAA plans a...
- Research articles 2001-09-24
- Bayer Unleashes Massive Effort In Biopharma
- Company may seek partners to strengthen its research in life sciences by 2002. BAYER IS PLANNING to spend around three quarters of its research budget on pharmaceuticals, diagnostics, crop protection and animal health by 2002 with the aim of maki Company may...
- Research articles 1998-06-22
- Frost & Sullivan's Opportunities in Life Science Molecules: Global Partnership Summit.
- MUMBAI, India, May 12 /PRNewswire/ -- From being an import-dependent industry in the 1950s, the Indian pharmaceuticals sector has come a long way to become the US$7 billion giant it is today. India is not only self-sufficient in terms of pharmace MUMBAI,...
- Research articles 2005-05-12
- AHP and Monsanto Merge to Form Colossal Life Science Firm.
- New company will dominate ag chemicals and biotech. AMERICAN HOME Products Corporation and Monsanto Company arc planning to merge in a $33 billion tax-free stock swap, creating the world's largest life sciences company with 75,000 employees and $2 New company will dominate ag...
- Research articles 1998-06-08
- Bayer Increases US Investments To $15 Billion.
- Company to ramp up R&D spending in healthcare and the life sciences. BAYER CORPORATION is launching a major expansion of its capital and research and development investments in the US, from $9 billion between 1995 and 2000, to $15 billion ...
- Research articles 1999-04-05
- Active Pharmaceuticals ingredient watch. (Markets: Life Sciences).(Abbott Laboratories reports 2001 sales of $16.3 bn)(Brief Article)(Statistical Data Included)
- ABBOTT Laboratories reported 2001 sales of $16.3 billion, up 18.5 percent year over year, which includes US pharmaceuticals sales of $3.76 billion and international pharmaceuticals sales of $2.52 billion. ABBOTT Laboratories reported 2001 sales of $16.3 billion, up 18.5 percent year over...
- Research articles 2002-01-21
- Perspectives on Life Sciences - Smart & Lean Operations
- This report draws on a survey of the world's pharmaceutical industry leaders working with the most innovative pharmaceutical companies. It articulates a growing consensus among the industry's executives that operations will have to play a far more prominent role in the future, and that the pharmaceutical supply chain must become...
- White papers 2004-04-14
- Verity PharmaCI: Using Information to Stay Ahead of the Competition in Life Sciences
- Pharmaceutical and biotechnology companies are under pressure to bring drugs to market quicker. Thus there is a need to maximize their return on each new drug introduced to the market, to comply with stringent government regulations, to understand the impact of patent expiration on their drug portfolio and to rapidly...
- White papers 2005-06-29
- SAP for Life Sciences in the Pharmaceutical Industry
- The life sciences industry is dynamic - always innovating, always in flux. What worked yesterday might not work today. That's why pharmaceutical, biotechnology, and medical device companies are constantly seeking better ways to manage complexity, comply with regulations, cut costs, and boost productivity. In pursuit of these objectives, life sciences...
- White papers 2003-12-02
- Using Information to Stay Ahead of the Competition in Life Sciences
- Pharmaceutical and biotechnology companies are under pressure to bring drugs to market quicker. The challenges confronting pharmaceutical companies are: to maximize their return on each new drug introduced to the market, to comply with stringent government regulations, to understand the impact of patent expiration on their drug portfolio and to...
- White papers 2005-06-29
- Waters Corp. Q4 FY08 Earnings Call
- Question-and-Answer SessionOperator [Operator Instruction] Your first question comes from Ross Muken, Deutsche Bank. Your line is open. Ross Muken - Deutsche Bank Good morning, gentlemen. Douglas Berthiaume Good morning Ross. Ross Muken - Deutsche Bank Can you walk us through on the instrument side, sort...
- Earnings calls 2009-01-27
- BMS Moves Forward On Aripiprazole, Vanlev. (Markets: Life Sciences).(Bristol-Myers Squibb Co., Otsuka Pharmaceutical Company Ltd.)(Brief Article)(Statistical Data Included)
- BRISTOL-MYERS SQUIBB Company BMS and Otsuka Pharmaceutical Co. Ltd. have filed for marketing approval in Europe for their schizophrenia drug aripiprazole. If approved, aripiprazole, a next generation atypical antipsychotic, will compete against P BRISTOL-MYERS SQUIBB Company BMS and Otsuka Pharmaceutical Co. Ltd. have...
- Research articles 2001-12-24
- BASF May Favor Life Sciences At the Expense of Pharmaceuticals.
- The company is concerned about drug sales in the US. BASF HINTED last week that it may dispose of part or all of its pharmaceutical business to strengthen its position in another life sciences sector, such as crop protection. ...
- Research articles 1999-11-15
Additional Resources
- Leading Global Pharmaceutical Company Expands Contract with Dendrite to Support its Canadian Field Force
- BEDMINSTER, N.J. -- Dendrite International, Inc. (NASDAQ: DRTE), a leading provider of sales, marketing and clinical solutions for the life science and pharmaceutical industries, today announced that the Canadian subsidiary of a leading global pharmaceutical company purchased additional licenses of Dendrite's WebForceTM and AnalyzerTM solutions -- both core components of...
- Research articles 2005-09-16
- Leading Pharmaceutical Company Engages Dendrite to Support Vital Customer Education Initiative; Company Cites Dendrite's Combination of Marketing Strategy and Delivery Capabilities as Key Driver in Selection
- BEDMINSTER, N.J. -- Dendrite International, Inc. (NASDAQ: DRTE) a leading provider of sales, marketing, clinical and compliance solutions for the life science and pharmaceutical industries, today announced that one of the world's largest research-driven pharmaceutical and health care products companies' is implementing Dendrite's marketing services solutions, including those from the...
- Research articles 2005-10-31
- << Previous
- page 1 of 1
- Next >>
